Status:
COMPLETED
Connecting Audio and Radio Sensing Systems to Improve Care at Home
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
U.S. National Science Foundation
National Library of Medicine (NLM)
Conditions:
Colorectal Cancer
Bladder Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
This study aims to assess the usability of the innovative Audio + Radio (AURA) system in enhancing personalized supportive care for cancer patients and caregivers during the post-ostomy care transitio...
Detailed Description
The investigators will assign up to 30 cancer patients with newly created ostomies for cancer treatment with curative intent and their primary caregivers to the AURA or usual care groups (up to 30 pat...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Phase I: The investigators will only be recruiting patients for this phase
- Patients must:
- have been surgically treated for colorectal or bladder cancer with curative intent;
- have had an ostomy with curative intent for at least 90 days;
- be able to read and speak English;
- be 18 years or older;
- Phase II: The investigators will be recruiting patients and caregivers as a dyad for this phase
- Patients must:
- have been surgically treated for colorectal or bladder cancer with curative intent;
- be within one month of hospital discharge of a newly created ostomy with curative intent;
- be able to read and speak English;
- be 18 years or older;
- have a caregiver who is willing to participate in the study;
- Caregivers must:
- be 18 years or older;
- be able to read and speak English;
- be identified as the primary caregiver by the patient;
- have not themselves been diagnosed with cancer or received cancer treatment during the study (to ensure that patients and caregivers focus their efforts on care of the patient).
- Exclusion Criteria
- Patients and their caregivers will be excluded if they:
- are unable to read, speak, or understand English;
- have more than one type of ostomy;
- have other cancer diagnosis (excluding non-melanomatous skin cancer); or
- have cognitive impairment (assessed by the Short Portable Mental Status Questionnaire).
Exclusion
Key Trial Info
Start Date :
March 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT05344950
Start Date
March 21 2022
End Date
July 31 2024
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599
2
UT Health San Antonio MD Anderson Cancer Center
San Antonio, Texas, United States, 78229